News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Pharmaceuticals, Inc. (IVX) Shareholders Overwhelmingly Elect To Receive Stock Consideration In Teva Pharmaceutical Industries Limited (TEVA) Merger


1/25/2006 12:41:49 PM

MIAMI--(BUSINESS WIRE)--Jan. 25, 2006--At the request of The American Stock Exchange, IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that an overwhelming majority of shareholders who made their elections prior to yesterday's deadline for making a cash or stock election under the merger agreement elected to receive stock consideration (0.8471 of a Teva ADR for each share of IVAX common stock). As a result, all shareholders who failed to make an election will receive cash consideration ($26.00 for each share of IVAX common stock).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES